Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran

J Pak Med Assoc. 2014 Feb;64(2):134-7.

Abstract

Objective: To determine the risk factors and frequency of hepatitis B and C virus co-infections in human immunodeficiency virus-positive patients.

Methods: The cross-sectional study was conducted at the Control of Diseases Centre of Kerman Medical University, southern Iran, between May and December 2011. Demographic features and history of high-risk behaviours were evaluated in 165 patients positive for human immunodeficiency virus. Third-generation hepatitis C virus antibody and hepatitis B surface antigen tests were performed by enzyme-linked immunosorbent assay method. SPSS 18 was used for statistical analysis.

Results: Out of the 165 patients, 136 (82.4%) were male and 29 (17.6%) were female. The mean age of the subjects was 40.4 +/- 9 years. Positive hepatitis C antibody was found in 122 (73.9%) and positive hepatitis B surface antigen was present in 6 (3.6%). Frequency of all three viruses co-infection was 3 (1.8%). History of imprisonment (OR = 17.5; 95% CI: 7.1-43.1) and drug injection addiction (OR = 15.3; 95% CI: 6.4-36.1) were the most significant risk factors involved in hepatitis C virus co-infection.

Conclusion: Seroprevalence of hepatitis C virus and human immunodeficiency virus co-infection was high and it was strongly related to history of imprisonment and drug injection addiction.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Coinfection
  • Cross-Sectional Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HIV Seropositivity / epidemiology*
  • HIV Seropositivity / psychology
  • Hepacivirus / immunology*
  • Hepatitis B / complications
  • Hepatitis B / epidemiology*
  • Hepatitis B / virology
  • Hepatitis B Antibodies / analysis
  • Hepatitis B virus / immunology*
  • Hepatitis C / complications
  • Hepatitis C / epidemiology*
  • Hepatitis C / virology
  • Hepatitis C Antibodies / analysis
  • Humans
  • Incidence
  • Iran / epidemiology
  • Male
  • Retrospective Studies
  • Risk Factors

Substances

  • Hepatitis B Antibodies
  • Hepatitis C Antibodies